Aquestive Therapeutics, Inc.
—- Market cap
- $670.23M
- Debt
- +$45.00M
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AQST stock price at premium vs HGV $5.34 current versus $0.23 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HGV's multiple
Implied fair value · at AQST's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AQST FY 2025 (ended Dec 31, 2025) · HGV FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt
Capital structure 42% equity / 58% debt · EV / Revenue 1.50x · EV / EBITDA 10.19x
HGV carries the larger enterprise value at $7.57B against $715.23M; HGV trades on the lower EV / Revenue multiple (1.50x vs 16.06x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Aquestive Therapeutics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Hilton Grand Vacations Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.34x
3.53x
Net debt / EBITDA
Leverage against operating earnings
—
5.80x
Cash and equivalents
Liquid reserves on the balance sheet
—
$239.00M
Total debt
Interest-bearing obligations outstanding
$45.00M
$4.55B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.